Numerous diseases can result from GPL metabolic problems, which can also cause insulin resistance, obesity, dyslipidemia, endoplasmic reticulum stress, and other metabolic abnormalities (Chen et al., 2022). This evidence concerns the gene IL31RA and Insulin resistance.